[
    [
        {
            "time": "2019-12-31",
            "original_text": "安图生物(603658.SH)2019年度净利润升37.61%至7.74亿元拟10派9元",
            "features": {
                "keywords": [
                    "安图生物",
                    "2019年度",
                    "净利润",
                    "增长",
                    "37.61%",
                    "分红"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "安图生物(603658.SH)2019年度净利润升37.61%至7.74亿元拟10派9元",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-03-31",
            "original_text": "安图生物(603658.SH)一季度净利润降23.08%至9311.97万元 盈利能力下降",
            "features": {
                "keywords": [
                    "安图生物",
                    "一季度",
                    "净利润",
                    "下降",
                    "23.08%",
                    "盈利能力"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "安图生物(603658.SH)一季度净利润降23.08%至9311.97万元 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-03-31",
            "original_text": "安图生物：一季度净利润同比减少23.08% 盈利能力下降",
            "features": {
                "keywords": [
                    "安图生物",
                    "一季度",
                    "净利润",
                    "减少",
                    "23.08%",
                    "盈利能力"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "安图生物：一季度净利润同比减少23.08% 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2019-12-31",
            "original_text": "安图生物：2019年净利润同比增长37.61%",
            "features": {
                "keywords": [
                    "安图生物",
                    "2019年",
                    "净利润",
                    "增长",
                    "37.61%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "安图生物：2019年净利润同比增长37.61%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        }
    ]
]